Differential expression of organic cation transporter 3 in oral submucous fibrosis-associated buccal squamous cell carcinoma

Yue Hu; Yunmei Qian; Lu Lin; Wenxin Chen; Liudi Yang; Xin Hu; Ke Tian; Kun Xia; Tong Su

doi:10.1016/j.oooo.2018.01.009

Differential expression of organic cation transporter 3 in oral submucous fibrosis-associated buccal squamous cell carcinoma

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Mar 6:S2212-4403(18)30045-2. doi: 10.1016/j.oooo.2018.01.009. Online ahead of print.

Authors

Yue Hu¹, Yunmei Qian², Lu Lin³, Wenxin Chen¹, Liudi Yang¹, Xin Hu¹, Ke Tian¹, Kun Xia⁴, Tong Su⁵

Affiliations

¹ Department of Oral and Maxillofacial Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
² Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, Guizhou, China.
³ Department of Stomatology, Beijing You'an Hospital, Capital Medical University, Beijing, China.
⁴ State Key Laboratory of Medical Genetics, Central South University, Changsha, Hunan, China.
⁵ Department of Oral and Maxillofacial Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address: sutongs@163.com.

PMID: 29523428
DOI: 10.1016/j.oooo.2018.01.009

Abstract

Objective: The aim of this study was to examine the expression of organic cation transporter 3 (OCT3) in patients with oral submucous fibrosis (OSF)-associated buccal squamous cell carcinoma (BSCC) and to explore its clinical significance.

Study design: A total of 56 tissue specimens were collected from patients, among which there were 13 specimens with normal buccal mucosa (NBM), 13 with oral submucous fibrosis (OSF), 10 with OSF-associated BSCC (BSCC-OSF), 10 with well-differentiated BSCC (BSCC-I), and 10 with poorly to moderately differentiated BSCC (BSCC-II+III), based on pathologic examination. The expression of OCT3 was detected by using immunohistochemistry and real-time quantitative reverse transcription polymerase chain reaction.

Results: There was a significant difference in both the protein and mRNA expression levels of OCT3 among the NBM, OSF, BSCC-OSF, BSCC-I, and BSCC-II+III groups (protein: F = 82.45 [P < .0001]; mRNA: F = 50.69 [P < .0001]). The expression of OCT3 from NBM to OSF to BSCC-OSF was gradually upregulated. In addition, as BSCC became better differentiated, the expression of OCT3 increased.

Conclusions: The expression of OCT3 was associated with OSF progression and the differentiation of BSCC. OCT3 expression may serve as a molecular marker for the prevention and early diagnosis of OSF and BSCC.